Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastrointest Endosc. Jul 25, 2015; 7(9): 889-894
Published online Jul 25, 2015. doi: 10.4253/wjge.v7.i9.889
Table 1 Patients characteristics in the two groups
VariableSingle-step (n = 49)Two-step (n = 41)P
Mean age (yr)70.1 ± 12.674.3 ± 9.9NS
Gender (n)
Male4923< 0.01
Female018
Etiology of MBO:
pancratic cancer (%)59.231.70.016
MPD tumor involvement present (%)36.724.4NS
Spincterotomy (%)2.022.00.003
Hilar biliary obstruction (%)22.446.30.03
Clinical stage
IVa > (%)40.861NS
IVb (%)59.239NS
Bilateral drainage (%)4.112.2NS
Technical success rate (%)93.995.1NS
Complication rate (%)4.14.8NS
Chemotherapy (%)55.151.2NS
Length of hospital stay (d)28.1 ± 28.639.6 ± 25.7< 0.05
Table 2 Multivariate analysis to identify the clinical prognostic factors for patient survival
VariablesOR95%CIP
Step (single vs two)0.810.49-1.360.42
Gender (male vs female)1.050.66-1.670.83
Age (69 ≥vs 70 < )1.020.59-1.760.96
Pancratic cancer (yes vs no)1.010.21-1.610.98
Clinical stage (IVa ≥vs IVb)2.031.23-3.340.006
Chemotherapy (with vs without)2.181.27-3.760.005
Patency of the stent (no vs yes)2.211.20-4.070.011